In focus · trending topic

Patient Dosing

2 stories · following the connections

VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients

By Nasdaq OMXApr 17, 2018, 12:01 PM UTC

VBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine

By Nasdaq OMXDec 19, 2017, 1:00 PM UTC